Person sneezing illustrating the importance of the “Stop Sneeze to Wheeze” initiative in combating Allergic Rhinitis and Asthma
Drug Updates

Uniting to Combat Respiratory Diseases: The Role of Awareness in Managing Allergic Rhinitis and Asthma

The “Stop Sneeze to Wheeze” initiative by Alkem Laboratories Ltd comes at a crucial time as the world observes Allergy Week. This campaign is aimed at raising awareness about the coexistence of Allergic Rhinitis and Asthma – conditions that often occur together and affect millions of people across the globe. Allergic Rhinitis, commonly known as […]

Drug Updates

Alkem Laboratories to launch state of the art technology for diabetic foot ulcer management

Alkem Laboratories Ltd. (Alkem) hereby announces to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India. The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter […]

Digital Health News

Alkem Laboratories Ltd. to Launch State of the Art Technology for Diabetic Foot Ulcer Management for the First Time in India

Alkem Laboratories Ltd. (Alkem) hereby announces to launch a unique patented technology for the treatment of Diabetic Foot Ulcer (DFU) in India. The solution would be based on disruptive 4D Bioprinting technology, which would be used to treat deep, non-healing chronic wounds and is expected to be launched in the Indian market in the latter half of 2022 post regulatory approval. This advanced technology for DFU management has a high scope of preventing […]